Reduced T2D plaque levels of all three TGF-β isoforms could be either due to an impaired enzymatic cleavage of TGF-β-LAPs complexes or less TGF-β expressing/secreting cells. This evidence concerns the gene TGFB1 and type 2 diabetes mellitus.